Skip to main content

News

Senator urges sodium valproate inquiry

Last Updated:

A senator is calling for an independent inquiry into sodium valproate (Epilim) – an epilepsy drug linked to birth defects. Rose Conway-Walsh, (Sinn Fein), told The Times Ireland Edition that a "do-nothing" approach was not acceptable.

Gerry Tobin: RIP

Last Updated:

Epilepsy Ireland is saddened to announce the death of Gerry Tobin while taking part in the Annual Tour De Gaggs cycle, an annual fundraiser on behalf of Epilepsy Ireland.

Epilepsy Ireland welcomes American decision to licence Epidiolex

Last Updated:

Yesterday's decision by the US Food and Drug Administration (FDA) to approve Epidiolex for the treatment of two rare and severe forms of epilepsy is a landmark moment not just for people with epilepsy in the US, but in Ireland and around the world as well.

Epidiolex is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive component of the cannabis plant.

FACS Forum welcomes HSE’s plans to contact patients directly regarding Sodium Valproate

Last Updated:

Epilepsy Ireland and our partner organisations in the FACS Forum Ireland welcomes that the Health Service Executive is taking the step of directly writing to women taking Sodium Valproate (Epilim) in the coming weeks to highlight the risks of the drug in pregnancy and to inform them of recent changes to how the drug is prescribed and monitored.

Low dosage of CBD may reduce seizures according to new study

Last Updated:

Cannabidiol (CBD) was shown in a new large-scale, randomized, controlled trial to reduce the number of seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome. The study was conducted with Epidiolex which is manufactured by GW Pharmaceuticals.

Minister Harris: "Parents have been let down"

Last Updated:

Minister for Health Simon Harris has stated that parents affected by the drug sodium valproate have been 'let down' after the issue was raised yesterday in the Dáil by Fianna Fail TD, Bobby Aylward.

The Minister met with a selection of parents affected by the drug last month and has expressed his commitment to the issue.

"Unlike in the past with other people in the Department of Health I've taken a very interest in this issue", said Minister Harris.

Irish plans to develop new cannabis-based treatment

Last Updated:

A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug resistant epilepsies, and in particular, childhood epilepsies.